What we offer
A wide range of advanced analytical and Health Economics and Outcomes Research (HEOR) consulting services that include effectiveness studies, real world data(RWD) collection, evidence generation and advanced health economic modeling
Who is it for
Medical affairs and HEOR leaders across pharmaceuticals, biotech and medical devices companies
Why it’s important
Demonstrate clinical and economical value of innovations
Close the gap between trial results and real-world outcomes
Enable data-driven decisions based on insights from multiple stakeholder behavior
How we deliver
Our highly experienced team of health economists brings in extensive expertise in RWD modeling, which reduces ambiguities and enables data-driven decisions. We bring together deep domain expertise, mature processes and proprietary NLP/ML clinical and statistical algorithms to generate RWE from primary and secondary real-world patient data.
Our multidisciplinary team of clinicians, medical writers, data scientists, and statisticians enable healthcare enterprises to assess impact of pharmaceutical products on quality of patient life, HCP’s knowledge, and attitude towards them. Our HEOR service portfolio also includes NLP-enabled literature reviews and Meta-Analysis/Network Meta-Analysis for systematic comparative effectiveness studies, clinical trial design, and scientific writing.